Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shuian
- Development stage
- Unknown
- Lead developer
- Consun Pharmaceutical
- Administration
- Oral
01
Overview
**Shuian** is a traditional Chinese multi-herb medicine product listed by Consun Pharmaceutical in oral capsule and tablet forms for insomnia. The sponsor describes it as regulating the viscera and treating insomnia without lethargy or dependence. The listed herbal composition includes fried spina date seed, Schisandra chinensis, Polygala tenuifolia, multiflower knotweed vine, Salvia miltiorrhiza root, Acorus gramineus rhizome, Anemarrhena rhizome, liquorice, and Poria cocos; the capsule listing additionally identifies calcium hydrogen phosphate and dextrin as excipients. ([chinaconsun.com](https://chinaconsun.com/en/index.php?ac=article&at=list&tid=99))
- Brand names
- ShuianShuian CapsulesShuian Tablets
- Other names
- 舒安胶囊舒安片
Beyond the preview
Go deeper on Shuian.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shuian.